Mobix Labs plans sale of 25,000 RSU shares

Mobix Labs filed a Form 144 reporting an intended sale of 25,000 shares of Common Stock tied to RSU vesting, scheduled on 05/01/2026 and described as equity compensation.

Rhea-AI Filing Summary

Mobix Labs filed a Form 144 reporting an intended sale of 25,000 shares of Common Stock tied to RSU vesting, scheduled on 05/01/2026 and described as equity compensation. The filing also records a prior sale of 8,702 shares on 02/02/2026 by a reported holder.

Key Figures

Shares to be sold: 25,000 shares Recent sale reported: 8,702 shares Filing date / record: 05/01/2026

3 metrics

Shares to be sold 25,000 shares RSU Vesting scheduled on 05/01/2026

Recent sale reported 8,702 shares Sale recorded on 02/02/2026 by a reported holder

Filing date / record 05/01/2026 Date appearing in the filing header and sale schedule

Key Terms

Form 144, RSU Vesting, equity compensation

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Vesting financial

"Common | 04/30/2026 | RSU Vesting"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

equity compensation financial

"05/01/2026 | equity compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Mobix Labs (MOBX) report in this Form 144?

Answer: The filing lists an intended sale of 25,000 shares from RSU vesting on 05/01/2026. It also notes a prior sale of 8,702 shares on 02/02/2026, both described as equity compensation transactions.

Who is the reported seller in the Mobix Labs Form 144?

Answer: The filing names a reported holder, Philip Sansone, in the recent activity. The document lists the prior sale on 02/02/2026 linked to that holder and the RSU vesting sale on 05/01/2026.

How many shares are listed for sale in the Mobix Labs Form 144?

Answer: The Form 144 shows 25,000 shares of Common Stock intended to be sold on 05/01/2026 as a result of RSU vesting. A prior sale of 8,702 shares is also recorded.

What type of securities and reason are listed in the filing for MOBX?

Answer: The securities are Common Stock, described as resulting from RSU vesting and categorized as equity compensation. The intended sale date is 05/01/2026.

Does the Form 144 indicate how proceeds will be used?

Answer: The filing lists the sale method as equity compensation linked to RSU vesting and does not state any use of proceeds. It records transaction dates and share counts only.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 02:38 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002067346
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Mobix Labs, Inc.
SEC File Number	001-40621
Address of Issuer	1 Venture Suite 220 Irvine CALIFORNIA 92618
Phone	949-808-8888
Name of Person for Whose Account the Securities are To Be Sold	Philip Sansone
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	9541	22463.58	10107223	05/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/30/2026	RSU Vesting	Mobix Labs (issuer)			25000	05/01/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Philip Sansone 1 Venture Irvine CA 92618	Common Stock	02/02/2026	8702	16360

144: Remarks and Signature

Remarks
Date of Notice	05/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for Philip Sansone, Mobix Labs, Inc.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)